APA (7th ed.) Citation

McNamara, M. G., Goyal, L., Doherty, M., Springfeld, C., Cosgrove, D., Sjoquist, K. M., . . . Knox, J. J. (2020). NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide: 121). Future oncology, 16(16), . https://doi.org/10.2217/fon-2020-0247

Chicago Style (17th ed.) Citation

McNamara, Mairéad Geraldine, et al. "NUC-1031/cisplatin Versus Gemcitabine/cisplatin in Untreated Locally Advanced/metastatic Biliary Tract Cancer (NuTide: 121)." Future Oncology 16, no. 16 (2020). https://doi.org/10.2217/fon-2020-0247.

MLA (9th ed.) Citation

McNamara, Mairéad Geraldine, et al. "NUC-1031/cisplatin Versus Gemcitabine/cisplatin in Untreated Locally Advanced/metastatic Biliary Tract Cancer (NuTide: 121)." Future Oncology, vol. 16, no. 16, 2020, https://doi.org/10.2217/fon-2020-0247.